5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.04▼ | 3.02▲ | 3.02▲ | 3.14▼ | 2.93▲ |
MA10 | 3.06▼ | 3.08▼ | 3.08▼ | 3.03▼ | 3.11▼ |
MA20 | 3.14▼ | 3.16▼ | 3.13▼ | 2.93▲ | 3.32▼ |
MA50 | 3.17▼ | 3.04▼ | 3.00▲ | 3.19▼ | 3.71▼ |
MA100 | 3.01▲ | 2.94▲ | 2.91▲ | 3.35▼ | 3.89▼ |
MA200 | 2.91▲ | 3.00▲ | 3.06▼ | 3.54▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.014▼ | -0.030▼ | -0.029▼ | 0.042▲ | -0.027▼ |
RSI | 40.117▼ | 43.859▼ | 45.433▼ | 48.433▼ | 44.510▼ |
STOCH | 29.545 | 12.809▼ | 12.809▼ | 65.953 | 18.452▼ |
WILL %R | -77.273▼ | -84.375▼ | -84.375▼ | -52.174 | -81.197▼ |
CCI | -62.901 | -77.762 | -77.778 | 20.904 | -40.579 |
MA | $SOPH Price Crossed Below MA(26) | Set Alert |
Tuesday, April 29, 2025 01:00 PM
1 Day SOPH 0.71% DJIA -1.33% Russell 2K 0.00% Technology -0.04% ...
|
Tuesday, April 29, 2025 01:52 AM
"Our collaboration with AstraZeneca represents a significant step toward scaling next-generation oncology diagnostics globally," said Ross Muken, President, SOPHiA GENETICS. "This expanded deployment ...
|
Tuesday, April 29, 2025 01:52 AM
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration with AstraZeneca (LSE ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 3.05 | 3.09 | 2.981 | 3.02 | 17,679 |
30/04/25 | 3.035 | 3.1965 | 3.0333 | 3.05 | 6,081 |
29/04/25 | 3.21 | 3.21 | 3.205 | 3.21 | 9,697 |
28/04/25 | 3.20 | 3.50 | 3.08 | 3.26 | 166,329 |
25/04/25 | 3.10 | 3.20 | 3.0445 | 3.16 | 22,717 |
24/04/25 | 3.04 | 3.11 | 3.03 | 3.05 | 6,536 |
23/04/25 | 3.00 | 3.26 | 2.99 | 3.06 | 14,378 |
22/04/25 | 2.77 | 3.06 | 2.77 | 2.91 | 15,214 |
21/04/25 | 2.80 | 2.82 | 2.58 | 2.78 | 53,359 |
17/04/25 | 2.76 | 2.88 | 2.70 | 2.83 | 19,163 |
|
|
||||
|
|
||||
|
|